drugset / Trial / NCT01111955
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on fasting plasma glucose (FPG).
Timeline
- Start
- 2010-07
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BMS-823778 | Small molecule | 2 mg | Oral |
| Comparator | BMS-823778 | Small molecule | 10 mg | Oral |
| Comparator | BMS-823778 | Small molecule | 20 mg | Oral |
| Comparator | Metformin | Small molecule | 1500 mg | Oral |